PMID- 32678798 OWN - NLM STAT- MEDLINE DCOM- 20210315 LR - 20210315 IS - 2291-5222 (Electronic) IS - 2291-5222 (Linking) VI - 8 IP - 9 DP - 2020 Sep 11 TI - Identification of Type 2 Diabetes Management Mobile App Features and Engagement Strategies: Modified Delphi Approach. PG - e17083 LID - 10.2196/17083 [doi] LID - e17083 AB - BACKGROUND: Diabetes is a significant public health issue. Saudi Arabia has the highest prevalence of type 2 diabetes mellitus (T2DM) in the Arab world. Currently, it affects 31.6% of the general population, and the prevalence of T2DM is predicted to rise to 45.36% by 2030. Mobile health (mHealth) offers improved and cost-effective care to people with T2DM. However, the efficiency of engagement strategies and features of this technology need to be reviewed and standardized according to stakeholder and expert perspectives. OBJECTIVE: The main objective of this study was to identify the most agreed-upon features for T2DM self-management mobile apps; the secondary objective was to identify the most agreed-upon strategies that prompt users to use these apps. METHODS: In this study, a 4-round modified Delphi method was applied by experts in the domain of diabetes care. RESULTS: In total, 11 experts with a mean age of 47.09 years (SD 11.70) consented to participate in the study. Overall, 36 app features were generated. The group of experts displayed weak agreement in their ranking of intervention components (Kendall W=0.275; P<.001). The top 5 features included insulin dose adjustment according to carbohydrate counting and blood glucose readings (5.36), alerting a caregiver of abnormal or critical readings (6.09), nutrition education (12.45), contacts for guidance if required (12.64), and offering patient-specific education tailored to the user's goals, needs, and blood glucose readings (12.90). In total, 21 engagement strategies were generated. Overall, the experts showed a moderate degree of consensus in their strategy rankings (Kendall W=0.454; P<.001). The top 5 engagement strategies included a user-friendly design (educational and age-appropriate design; 2.82), a free app (3.73), allowing the user to communicate or send information/data to a health care provider (HCP; 5.36), HCPs prescribing the mobile app in the clinic and asking about patients' app use compliance during clinical visits (6.91), and flexibility and customization (7.91). CONCLUSIONS: This is the first study in the region consisting of a local panel of experts from the diabetes field gathering together. We used an iterative process to combine the experts' opinions into a group consensus. The results of this study could thus be useful for health app developers and HCPs and inform future decision making on the topic. CI - (c)Hanan A Alenazi, Amr Jamal, Mohammed A Batais. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 11.09.2020. FAU - Alenazi, Hanan A AU - Alenazi HA AUID- ORCID: 0000-0003-0689-4909 AD - National Health Information Center, Riyadh, Saudi Arabia. FAU - Jamal, Amr AU - Jamal A AUID- ORCID: 0000-0002-4051-6592 AD - Family and Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. AD - Research Chair of Evidence-Based Healthcare and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia. FAU - Batais, Mohammed A AU - Batais MA AUID- ORCID: 0000-0001-6766-7553 AD - Family and Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200911 PL - Canada TA - JMIR Mhealth Uhealth JT - JMIR mHealth and uHealth JID - 101624439 SB - IM MH - *Diabetes Mellitus, Type 2/epidemiology/therapy MH - Female MH - Humans MH - Middle Aged MH - *Mobile Applications MH - Saudi Arabia/epidemiology MH - State Medicine PMC - PMC7519429 OTO - NOTNLM OT - Delphi consensus OT - diabetes OT - engagement strategies OT - mobile app OT - mobile features COIS- Conflicts of Interest: None declared. EDAT- 2020/07/18 06:00 MHDA- 2021/03/16 06:00 PMCR- 2020/09/11 CRDT- 2020/07/18 06:00 PHST- 2019/11/16 00:00 [received] PHST- 2020/06/03 00:00 [accepted] PHST- 2020/04/25 00:00 [revised] PHST- 2020/07/18 06:00 [pubmed] PHST- 2021/03/16 06:00 [medline] PHST- 2020/07/18 06:00 [entrez] PHST- 2020/09/11 00:00 [pmc-release] AID - v8i9e17083 [pii] AID - 10.2196/17083 [doi] PST - epublish SO - JMIR Mhealth Uhealth. 2020 Sep 11;8(9):e17083. doi: 10.2196/17083.